ITGAX and colitis: In addition, CD11c+ expression was significantly elevated in DSS-treated WT mice compared to WT healthy controls (p < 0.05) but was decreased by 55% upon sulfasalazine treatment, indicating a partial recovery effect of sulfasalazine in modulating immune responses during colitis (Figure 3J).